Jeff Yass’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $243K | Sell |
11,031
-19,374
| -64% | -$389K | ﹤0.01% | 11476 |
|
|
2026
Q2 | $624K | Sell |
30,405
-7,673
| -20% | -$130K | ﹤0.01% | 9385 |
|
|
2026
Q1 | $605K | Buy |
38,078
+27,310
| +254% | +$593K | ﹤0.01% | 9169 |
|
|
2025
Q4 | $283K | Sell |
10,768
-9,531
| -47% | -$247K | ﹤0.01% | 10082 |
|
|
2025
Q3 | $459K | Sell |
20,299
-149,666
| -88% | -$3.08M | ﹤0.01% | 9164 |
|
|
2025
Q2 | $3.38M | Buy |
169,965
+108,227
| +175% | +$2.11M | ﹤0.01% | 4727 |
|
|
2025
Q1 | $1.04M | Buy |
61,738
+34,496
| +127% | +$588K | ﹤0.01% | 7154 |
|
|
2024
Q4 | $503K | Buy |
27,242
+12,675
| +87% | +$247K | ﹤0.01% | 8645 |
|
|
2024
Q3 | $317K | Buy |
+14,567
| New | +$326K | ﹤0.01% | 9485 |
|
|
2024
Q2 | – | Sell |
-67,686
| Closed | -$1.41M | – | 12372 |
|
|
2024
Q1 | $1.47M | Buy |
67,686
+52,864
| +357% | +$1.31M | ﹤0.01% | 6055 |
|
|
2023
Q4 | $429K | Buy |
+14,822
| New | +$397K | ﹤0.01% | 9046 |
|
|
2023
Q3 | – | Sell |
-53,975
| Closed | -$1.84M | – | 12288 |
|
|
2023
Q2 | $2M | Sell |
53,975
-35,503
| -40% | -$1.24M | ﹤0.01% | 5167 |
|
|
2023
Q1 | $2.79M | Buy |
89,478
+2,059
| +2% | +$66.3K | ﹤0.01% | 4459 |
|
|
2022
Q4 | $2.6M | Sell |
87,419
-31,630
| -27% | -$1.13M | ﹤0.01% | 4242 |
|
|
2022
Q3 | $4.54M | Buy |
119,049
+62,463
| +110% | +$3.13M | ﹤0.01% | 3319 |
|
|
2022
Q2 | $3.09M | Buy |
56,586
+6,990
| +14% | +$384K | ﹤0.01% | 4017 |
|
|
2022
Q1 | $3.1M | Sell |
49,596
-17,715
| -26% | -$1.17M | ﹤0.01% | 4565 |
|
|
2021
Q4 | $6.77M | Sell |
67,311
-46,951
| -41% | -$4.13M | ﹤0.01% | 3254 |
|
|
2021
Q3 | $10.3M | Sell |
114,262
-50,357
| -31% | -$4.58M | ﹤0.01% | 2823 |
|
|
2021
Q2 | $15.2M | Buy |
164,619
+20,281
| +14% | +$1.62M | ﹤0.01% | 2361 |
|
|
2021
Q1 | $13.9M | Buy |
144,338
+43,484
| +43% | +$4.49M | ﹤0.01% | 2323 |
|
|
2020
Q4 | $5.25M | Buy |
+100,854
| New | +$4.21M | ﹤0.01% | 3342 |
|
|
2020
Q2 | – | Sell |
-98,923
| Closed | -$1.06M | – | 10344 |
|
|
2020
Q1 | $1.06M | Buy |
98,923
+45,800
| +86% | +$638K | ﹤0.01% | 5265 |
|
|
2019
Q4 | $685K | Buy |
+53,123
| New | +$631K | ﹤0.01% | 6301 |
|
|
2018
Q4 | – | Sell |
-25,298
| Closed | -$99K | – | 9229 |
|
|
2018
Q3 | $99K | Buy |
25,298
+5,570
| +28% | +$23.8K | ﹤0.01% | 8606 |
|
|
2018
Q2 | $82K | Buy |
19,728
+8,749
| +80% | +$34.7K | ﹤0.01% | 9121 |
|
|
2018
Q1 | $44K | Buy |
+10,979
| New | +$48.3K | ﹤0.01% | 8988 |
|
Other funds holding FLGT
Jeff Yass's FLGT Position: Q3 2026 in Review
Jeff Yass reduced its Fulgent Genetics (FLGT) stake by 64% in Q3 2026, selling an estimated $389K and leaving 11,031 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #11476.
Jeff Yass first reported a position in FLGT in Q1 2018 and has held it in 27 quarters since. The position peaked at $15.2M in Q2 2021. 140 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.
- Jeff Yass held 11,031 shares of Fulgent Genetics worth $243K as of Q3 2026.
- Jeff Yass sold 19,374 Fulgent Genetics shares in Q3 2026, an estimated $389K.
- Fulgent Genetics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11476 holding.
- Jeff Yass first reported a position in Fulgent Genetics in Q1 2018 and has held it in 27 quarters since.
- Jeff Yass's Fulgent Genetics position peaked at $15.2M in Q2 2021.
- 140 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.